TrialThe British journal of ophthalmology2008

Pegaptanib sodium for neovascular age-related macular degeneration: third-year safety results of the VEGF Inhibition Study in Ocular Neovascularisation (VISION) trial.

L J Singerman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.